Gaithersburg molecular diagnostics company OpGen Inc. intends to raise about $18.7 million in its initial public offering expected sometime this week.
That’s less than the $37.5 million the company indicated it would raise when it initially filed to go public last month. In their latest regulatory filing, officials said the company is offering 2.5 million units, each consisting of one share of common stock and one warrant to purchase one additional share of common stock within the next five years. OpGen anticipates an IPO share price of between $5.50 and $6.50.
{iframe}http://www.bizjournals.com/washington/blog/2015/04/a-local-biotech-is-expected-to-go-public-this-week.html?ana=e_wash_rdup&s=newsletter&ed=2015-04-28&u=wjGEy67ABoSnsLErlc5ry0j5hx3&t=1430309654{/iframe}